AdAlta Limited (ASX:1AD)
Australia · Delayed Price · Currency is AUD 0.0050
+0.0010 (25.00%)
Mar 4, 2026, 4:10 PM AEST
AdAlta Market Cap
AdAlta has a market cap or net worth of 11.47 million as of March 3, 2026. Its market cap has increased by 6.89% in one year.
Market Cap
11.47M
Enterprise Value
9.89M
Revenue
608.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since August 22, 2016, AdAlta's market cap has decreased from 28.00M to 11.47M, a decrease of -59.02%. That is a compound annual growth rate of -8.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 11.47M | 66.63% |
| Dec 31, 2025 | 6.89M | -31.84% |
| Dec 30, 2024 | 10.10M | -19.94% |
| Dec 29, 2023 | 12.62M | -2.04% |
| Dec 29, 2022 | 12.88M | -45.79% |
| Dec 29, 2021 | 23.76M | -22.47% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurotech International | 16.85M |
| Tissue Repair | 10.88M |
| Bio-Gene Technology | 10.07M |
| Invex Therapeutics | 9.39M |
| Immuron | 9.11M |
| Biotron | 8.11M |
| Vectus Biosystems | 7.21M |
| Nexalis Therapeutics | 7.09M |